-transparent.png){kind=logo}
In a double-blind study involving 430 patients, Locacorten (0.02%)-Vioform (3%) cream was found to be highly effective in the treatment of dermatological conditions complicated by secondary bacterial involvement. Themicrobiological conversion and clinical improvement in patients treated with Locacorten-Vioform combinations were markedly greater than those achieved in the groups medicated with (1) Vioform 3%, (2) Locacorten 0.02%, and (3) placebo cream. Staphylococcus aureus was the most prevalent organism isolated from the skin lesions. All strains were sensitive to Vioform, as compared to 62% found to be resistant to other antimicrobials.
Related Publications
E A Konopka, and
E F Kimble, and
H C Zogans, and
H Heyman
February 1967,
Western medicine; the medical journal of the west,
E A Konopka, and
E F Kimble, and
H C Zogans, and
H Heyman
November 1958,
Texas state journal of medicine,
E A Konopka, and
E F Kimble, and
H C Zogans, and
H Heyman
October 1966,
Praxis,
E A Konopka, and
E F Kimble, and
H C Zogans, and
H Heyman
August 1967,
Zeitschrift fur Haut- und Geschlechtskrankheiten,
E A Konopka, and
E F Kimble, and
H C Zogans, and
H Heyman
October 1966,
Die Medizinische Welt,
E A Konopka, and
E F Kimble, and
H C Zogans, and
H Heyman
August 1977,
Ceskoslovenska otolaryngologie,
E A Konopka, and
E F Kimble, and
H C Zogans, and
H Heyman
April 1958,
Industrial medicine & surgery,
E A Konopka, and
E F Kimble, and
H C Zogans, and
H Heyman
June 1967,
Praxis,
E A Konopka, and
E F Kimble, and
H C Zogans, and
H Heyman
December 1968,
Vestnik dermatologii i venerologii,
E A Konopka, and
E F Kimble, and
H C Zogans, and
H Heyman
September 1971,
Zeitschrift fur Haut- und Geschlechtskrankheiten,
